Here are links to the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways [PubMed Abstract] [Full Text HTML] [Full Text PDF]. J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26.
The above article has been cited by 19 PubMed Central articles.
Note to myself: In addition to the above please review:
- Link To And Excerpts From The Vidcast And Transcript To “ACC Pathway Empowers Cardiologists to Use Diabetes Drugs for Heart Disease” From Medscape. Posted on November 1, 2019 by Tom Wade MD
- Link To And Excerpts From The Article ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD. Posted on November 2, 2019 by Tom Wade MD
- Link To “Video | ACC Decision Pathway on CV Risk Reduction in T2D and ASCVD: Key Points from the 2019 ACC Task Force on Expert on Expert Consensus Decision Pathways”. Posted on November 2, 2019 by Tom Wade MD
- Links To And Excerpts From “2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease”. Posted on November 2, 2019 by Tom Wade MD
